PERSON DIRECTORY
Chamath Palihapitiya
Host of All-In. Chamath Palihapitiya appears in 108 indexed conversations across All-In. This directory brings every appearance, source, TL;DR, digest, and transcript into one searchable feed.
They're Opening the Stock Market to Everyone. Here's What That Actually Means
Jason CalacanisChamath PalihapitiyaPaul AtkinsMichael Selig
SEC Chair Atkins wants to restore the IPO as a financing round through material-disclosure reform, less litigation, and review of quarterly reporting and accreditation rules.CFTC Chair Selig is replacing regulation by enforcement with purpose-fit frameworks for crypto, prediction markets, AI, and blockchain, while agencies pursue coordinated oversight.Tokenization could enable T+0 settlement and broader onshore innovation, but autonomous trading, manipulation, leverage, and gambling-related harms remain unresolved monitoring risks.
Trump vs Powell, Solving the Debt Crisis, The $10T AGI Prize, GENIUS Act Becomes Law
Chamath PalihapitiyaJason CalacanisDavid SacksDavid FriedbergGavin BakerBo HinesBill Hagerty
A Powell firing could damage Fed independence while refinancing $36 trillion of debt near the 5% 30-year yield pushes interest expense toward $2 trillion.GENIUS makes regulated dollar stablecoins payment infrastructure and a potential Treasury-demand catalyst, while CLARITY remains the next legislative milestone.
DOGE vs USAID, Crypto Framework, Google's $75B AI Spend, US Sovereign Wealth Fund, GLP-1s
Chamath PalihapitiyaJason CalacanisDavid SacksDavid FriedbergAntonio Gracias
Crypto’s policy path is stablecoin legislation followed by a FIT21-style market-structure bill, with Sacks citing alignment among all four relevant committee chairs and passage within several months as plausible.Google’s $75B 2025 capex plan looks like a utilization and ROIC test: a 20% return plus six-year amortization requires roughly $27B in incremental annual operating profit.A US sovereign wealth fund remains divided between strategic reinvestment and disciplined asset sales, while GLP-1 benefits and muscle and bone-density loss remain unresolved.